David Schiff
Program Director · University of Virginia Medical Center
Credentials: · · ·
History
- 1989–1993
Neurology
- 1984–1988
Research
A randomized trial of bevacizumab for newly diagnosed glioblastoma
New England Journal of Medicine · 2014 · 2,221 citations
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
Journal of Clinical Oncology · 2009 · 2,000 citations
Review · Neuro-Oncology · 2020 · 995 citations
- PW
85 papers
34 papers
30 papers · 3 as a fellow
29 papers
24 papers
24 papers
- LA
24 papers
24 papers
Clinical trials
- 2014–2015
Principal investigator · Terminated · Phase 2
Cortice Biosciences, Inc.
- 2008–2010
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma
Principal investigator · Unknown · Phase 1, Phase 2
TransMolecular
- 2020–2023
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
Study chair · Completed · Phase 1, Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2009–2026
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Study chair · Active not recruiting · Phase 3
Eastern Cooperative Oncology Group